Solventum Corporation (SOLV)
(Delayed Data from NYSE)
$73.68 USD
+1.27 (1.75%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $73.71 +0.03 (0.04%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SOLV 73.68 +1.27(1.75%)
Will SOLV be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for SOLV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SOLV
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
Will Solventum (SOLV) Beat Estimates Again in Its Next Earnings Report?
SOLV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Want Better Returns? Don?t Ignore These 2 Medical Stocks Set to Beat Earnings
SOLV or MEDP: Which Is the Better Value Stock Right Now?
Take the Zacks Approach to Beat the Markets: Phibro Animal Health, Travelzoo, Ollie's Bargain Outlet in Focus
Other News for SOLV
Solventum commits to 100% renewable electricity by 2030
Solventum Reaches Analyst Target Price
Solventum appoints Ryan Egeland as CMO
Solventum appoints Ryan Egeland as Chief Medical Officer
Buy 4 October Dividend Aristocrats & Watch 10